Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRTPF)

Cardiol Therapeutics (CRTPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CRTPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.4200 +1.65%
on 05/18/21
2.8300 -13.07%
on 06/08/21
-0.2000 (-7.52%)
since 05/14/21
3-Month
2.2503 +9.32%
on 05/13/21
3.9800 -38.19%
on 03/23/21
-0.9400 (-27.65%)
since 03/16/21
52-Week
1.4800 +66.22%
on 08/12/20
4.1900 -41.29%
on 02/18/21
+0.4300 (+21.18%)
since 06/16/20

Most Recent Stories

More News
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

/PRNewswire/ -- The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get...

OILFF : 0.1895 (+0.80%)
OILS.CN : 0.230 (-2.13%)
MNMD : 3.73 (+3.04%)
LKYSF : 0.8230 (+0.88%)
NUMI.VN : 1.020 (+2.00%)
FTRPF : 6.0100 (+1.02%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.4600 (-1.66%)
CRDL.TO : 3.03 (-0.98%)
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

Oakville, Ontario--(Newsfile Corp. - April 28, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 3.03 (-0.98%)
CRTPF : 2.4600 (-1.66%)
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - April 12, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 3.03 (-0.98%)
CRTPF : 2.4600 (-1.66%)
Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A

Oakville, Ontario--(Newsfile Corp. - April 1, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 3.03 (-0.98%)
CRTPF : 2.4600 (-1.66%)
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer

Oakville, Ontario--(Newsfile Corp. - March 30, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

AMGN : 239.58 (-0.11%)
CRDL.TO : 3.03 (-0.98%)
CRTPF : 2.4600 (-1.66%)
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - () () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of...

CRDL.TO : 3.03 (-0.98%)
CRTPF : 2.4600 (-1.66%)
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

Oakville, Ontario--(Newsfile Corp. - January 21, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for...

CRTPF : 2.4600 (-1.66%)
CRDL.TO : 3.03 (-0.98%)
Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences

Oakville, Ontario--(Newsfile Corp. - January 7, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, announced...

CRTPF : 2.4600 (-1.66%)
CRDL.TO : 3.03 (-0.98%)
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - December 22, 2020) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased...

CRTPF : 2.4600 (-1.66%)
CRDL.TO : 3.03 (-0.98%)
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

() () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"), announces...

CRTPF : 2.4600 (-1.66%)
CRDL.TO : 3.03 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 2.6127
2nd Resistance Point 2.5813
1st Resistance Point 2.5207
Last Price 2.4600
1st Support Level 2.4287
2nd Support Level 2.3973
3rd Support Level 2.3367

See More

52-Week High 4.1900
Fibonacci 61.8% 3.1548
Fibonacci 50% 2.8350
Fibonacci 38.2% 2.5152
Last Price 2.4600
52-Week Low 1.4800

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar